Please assess the completion status of the following clinical trial:

Trial Title: Determination of Coronary Flow Reserve by Dynamic Myocardial Perfusion Scintigraphy

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Patients sent to the Nuclear Medicine Department as part of a functional evaluation by dynamic acquisition tomoscintigraphy and who will benefit from coronary angiography in the Louis Pradel Hospital hemodynamics department, depending on the results and the clinical context , outside of an emergency context.~* Patients who received the information and did not object to participate in the study~Exclusion Criteria:~* Patient with a contraindication to pharmacological stress by dipyridamole or regadenoson (acute coronary syndrome, acute pulmonary embolism, hypertension) severe pulmonary artery disease, acute aortic dissection, symptomatic aortic stenosis, hemodynamic instability, acute myocarditis, pericarditis or endocarditis, severe chronic obstructive pulmonary disease, uncompacted type III atrioventricular block, systolic pressure \<90 mmHg, Recent ischemic stroke, hypersensitivity or allergy to active ingredients or excipients)~* Patients under 18 years of age~* Patients with atrial fibrillation complete arrhythmia (ACFA)~* Patients with a history of coronary bypass grafting.~* Patients whose clinical condition requires rapid management not allowing to wait for the completion of the exams~* Pregnancy and breast feeding~* Deprivation of civil rights (guardianship, guardianship, safeguard of justice)

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Patients with or suspected coronary heart disease (Type: None): None

Based on this trial design, predict the completion outcome and termination type (if applicable).